How sex differences impact treatment efficacy for chronic pain
March 20th 2025Discover how historical biases in chronic pain research have led to treatment disparities between men and women and how new findings are paving the way for more effective management strategies, as discussed by Tuan Trang, PhD.
Low creatinine-to-cystatin C ratio linked to postmenopausal muscle loss
March 20th 2025A new study finds that postmenopausal women with a reduced creatinine-to-cystatin C ratio experience decreased muscle volume and slower walking speed, highlighting its role as a potential biomarker for muscle health.
Tuan Trang, PhD, discusses biological differences in chronic pain between men and women
March 19th 2025Researchers have discovered that leptin, a hormone linked to energy metabolism, plays a crucial role in driving neuropathic pain in women but not in men, opening the door to targeted pain treatments.
sFLT1/PLGF ratio may improve risk stratification for birth outcomes
March 17th 2025A recent study suggests that the soluble fms-like tyrosine kinase 1 to placental growth factor ratio can help predict clinical deterioration, intrapartum fetal distress, and mode of delivery, offering valuable insights for patient counseling and labor management.
Revi System shows efficacy against urgency urinary incontinence
March 12th 2025John PFA Heesakkers, MD, PhD, MBA, with Maastricht Universitair Medisch Centrum, highlights a study revealing that the Revi System significantly reduces urinary incontinence episodes, offering a side-effect-free alternative to traditional treatments with high patient satisfaction.
Researchers highlight risks of breastfeeding while taking Levetiracetam
March 11th 2025Shirley Wang, a PhD student in the School of Pharmacy at the University of Waterloo, discusses the findings on Levetiracetam’s safety during breastfeeding and how mothers can make informed decisions about medication use and infant health.